Searching News Database: VIVO
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 8 May 2026
Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
HSMN NewsFeed - 31 Mar 2025
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 31 Mar 2025
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
HSMN NewsFeed - 23 Dec 2024
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
HSMN NewsFeed - 11 Apr 2024
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
HSMN NewsFeed - 9 Aug 2023
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
HSMN NewsFeed - 3 Aug 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
HSMN NewsFeed - 28 Feb 2023
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
HSMN NewsFeed - 7 Jul 2022
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
HSMN NewsFeed - 13 Jun 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
HSMN NewsFeed - 20 May 2022
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza(TM) for the Treatment of AADC Deficiency
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza(TM) for the Treatment of AADC Deficiency
HSMN NewsFeed - 17 Mar 2022
New Cardinal Health Surgical Drape Helps Reduce Surgical Site Contamination Risk
New Cardinal Health Surgical Drape Helps Reduce Surgical Site Contamination Risk
HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
HSMN NewsFeed - 7 Oct 2021
AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital
AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital
HSMN NewsFeed - 30 Aug 2021
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
HSMN NewsFeed - 27 Jul 2021
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
HSMN NewsFeed - 8 Jun 2021
Umoja Biopharma Announces Appointment of David Fontana, Ph.D., as Chief Business and Strategy Officer
Umoja Biopharma Announces Appointment of David Fontana, Ph.D., as Chief Business and Strategy Officer
HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
HSMN NewsFeed - 28 Jan 2021
Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities
Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities
HSMN NewsFeed - 16 Nov 2020
iSTAR Medical's glaucoma device MINIject shows positive one-year results in European trial
iSTAR Medical's glaucoma device MINIject shows positive one-year results in European trial
HSMN NewsFeed - 12 Nov 2020
Kira Pharmaceuticals Launches to Pioneer Novel Therapeutics for Complement-Mediated Diseases
Kira Pharmaceuticals Launches to Pioneer Novel Therapeutics for Complement-Mediated Diseases
HSMN NewsFeed - 27 Jul 2020
AxoProtego Therapeutics Announces Novel Investigational Agent for Chemotherapy-Induced Peripheral Neuropathy
AxoProtego Therapeutics Announces Novel Investigational Agent for Chemotherapy-Induced Peripheral Neuropathy
HSMN NewsFeed - 20 Apr 2020
Moleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus Testing
Moleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus Testing
HSMN NewsFeed - 11 Mar 2020
INVOcell Appoints Yve Lyppens as Director Business Development Asia Pacific
INVOcell Appoints Yve Lyppens as Director Business Development Asia Pacific
HSMN NewsFeed - 19 Feb 2020
Duke University and Leica Microsystems Establish Center of Excellence in Microscopy
Duke University and Leica Microsystems Establish Center of Excellence in Microscopy
HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
HSMN NewsFeed - 23 Jan 2020
iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development
iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development
HSMN NewsFeed - 8 Jan 2020
Revitope Oncology Appoints Steve Arkinstall, D.Phil., as Chief Executive Officer
Revitope Oncology Appoints Steve Arkinstall, D.Phil., as Chief Executive Officer
HSMN NewsFeed - 15 Jul 2019
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
HSMN NewsFeed - 18 Jan 2019
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
HSMN NewsFeed - 29 Nov 2018
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
HSMN NewsFeed - 17 Sep 2018
Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
HSMN NewsFeed - 19 Jul 2018
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 13 Jun 2018
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
HSMN NewsFeed - 6 Mar 2018
Smith & Nephew announces full commercial release of JOURNEY(TM) II XR Total Knee Arthroplasty
Smith & Nephew announces full commercial release of JOURNEY(TM) II XR Total Knee Arthroplasty
HSMN NewsFeed - 8 Feb 2018
N8 Medical Submits IDE for Breakthrough CeraShield(TM) Endotracheal Tube Device
N8 Medical Submits IDE for Breakthrough CeraShield(TM) Endotracheal Tube Device
HSMN NewsFeed - 1 Feb 2018
Grünenthal Group Receives FDA's Expedited Access Pathway Designation for VIVO
Grünenthal Group Receives FDA's Expedited Access Pathway Designation for VIVO
HSMN NewsFeed - 16 Jan 2018
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
HSMN NewsFeed - 20 Jul 2017
Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA(TM) by the U.S. FDA
Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA(TM) by the U.S. FDA
HSMN NewsFeed - 13 Jun 2017
Vertera Spine Receives New CMS ICD-10 Code for Radiolucent Porous Interbody Fusion Devices
Vertera Spine Receives New CMS ICD-10 Code for Radiolucent Porous Interbody Fusion Devices
HSMN NewsFeed - 30 May 2017
AMO Pharma Announces FDA Fast Track Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy
AMO Pharma Announces FDA Fast Track Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy
HSMN NewsFeed - 24 May 2017
DERMABOND(R) PRINEO(R) Skin Closure System May Improve Outcomes and Lower Hospital Costs
DERMABOND(R) PRINEO(R) Skin Closure System May Improve Outcomes and Lower Hospital Costs
HSMN NewsFeed - 17 May 2017
Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR
Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR
HSMN NewsFeed - 8 May 2017
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
HSMN NewsFeed - 28 Mar 2017
ONL Therapeutics Strengthens Leadership with Addition to Board of Directors and Expansion of Operations Team
ONL Therapeutics Strengthens Leadership with Addition to Board of Directors and Expansion of Operations Team
HSMN NewsFeed - 17 Oct 2016
Teleflex Receives FDA Clearance for the Arrow(R) Midline with Chlorag+ard(R) Technology
Teleflex Receives FDA Clearance for the Arrow(R) Midline with Chlorag+ard(R) Technology
HSMN NewsFeed - 12 Oct 2016
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
HSMN NewsFeed - 12 Oct 2016
RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.
RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.
HSMN NewsFeed - 10 Oct 2016
Teleflex Receives FDA Clearance for ARROW(R)JACC with Chlorag+ard(R) Technology and Tunneler
Teleflex Receives FDA Clearance for ARROW(R)JACC with Chlorag+ard(R) Technology and Tunneler
HSMN NewsFeed - 5 Aug 2016
ScinoPharm and CVie Therapeutics Limited to Jointly Develop New Heart Failure Drug
ScinoPharm and CVie Therapeutics Limited to Jointly Develop New Heart Failure Drug
HSMN NewsFeed - 4 Aug 2016
Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs
Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs
HSMN NewsFeed - 22 Jun 2016
AirXpanders' AeroForm(R) Tissue Expander Technology Showcased at Three International Surgery Conferences
AirXpanders' AeroForm(R) Tissue Expander Technology Showcased at Three International Surgery Conferences
HSMN NewsFeed - 6 Jun 2016
Homology Medicines Appoints James Warren, Ph.D. as Vice President of Manufacturing
Homology Medicines Appoints James Warren, Ph.D. as Vice President of Manufacturing
HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
HSMN NewsFeed - 5 May 2016
Bicycle Therapeutics Strengthens Product Development Capabilities with Key Leadership Appointments
Bicycle Therapeutics Strengthens Product Development Capabilities with Key Leadership Appointments
HSMN NewsFeed - 11 Apr 2016
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
HSMN NewsFeed - 8 Mar 2016
Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls
Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls
HSMN NewsFeed - 1 Mar 2016
New Elekta iViewDose Software Designed to Provide an Essential Safety Check for Radiation Therapy
New Elekta iViewDose Software Designed to Provide an Essential Safety Check for Radiation Therapy
HSMN NewsFeed - 5 Feb 2016
Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
HSMN NewsFeed - 13 Oct 2015
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
HSMN NewsFeed - 5 Oct 2015
Novocure Announces CE Mark and First Patient Use of Second Generation Optune System
Novocure Announces CE Mark and First Patient Use of Second Generation Optune System
HSMN NewsFeed - 15 Jul 2015
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
HSMN NewsFeed - 9 Jun 2015
Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development
Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development
HSMN NewsFeed - 16 Mar 2015
Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer
Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer
HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
HSMN NewsFeed - 16 Sep 2014
Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners
Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners
HSMN NewsFeed - 27 Aug 2014
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 15 Apr 2014
AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia
AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia
HSMN NewsFeed - 3 Apr 2014
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
HSMN NewsFeed - 30 Dec 2013
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
HSMN NewsFeed - 20 Nov 2013
Moderna Therapeutics Announces New Equity Financing, Raising $110M to Develop messenger RNA Therapeutics(TM)
Moderna Therapeutics Announces New Equity Financing, Raising $110M to Develop messenger RNA Therapeutics(TM)
HSMN NewsFeed - 7 Nov 2013
Smith & Nephew Introduces Advanced Biocomposite Material for Use in Arthroscopic Surgery
Smith & Nephew Introduces Advanced Biocomposite Material for Use in Arthroscopic Surgery
HSMN NewsFeed - 18 Oct 2013
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
HSMN NewsFeed - 3 Oct 2013
AngioDynamics Announces First Patient Enrolled in PICC Related Obstruction of Flow (PROOF) Study
AngioDynamics Announces First Patient Enrolled in PICC Related Obstruction of Flow (PROOF) Study
HSMN NewsFeed - 1 Oct 2013
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
HSMN NewsFeed - 31 Jul 2013
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
HSMN NewsFeed - 22 May 2013
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
HSMN NewsFeed - 26 Apr 2013
NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE Imaging System
NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE Imaging System
HSMN NewsFeed - 22 Jan 2013
NCCN Guidelines(R) Recommend NovoTTF(TM) Therapy as a Standard Treatment Option for CNS Cancers
NCCN Guidelines(R) Recommend NovoTTF(TM) Therapy as a Standard Treatment Option for CNS Cancers
HSMN NewsFeed - 27 Nov 2012
TransMedics, Inc. Secures $36 Million Round of Financing Led by Abrams Capital Management
TransMedics, Inc. Secures $36 Million Round of Financing Led by Abrams Capital Management
HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
HSMN NewsFeed - 21 Sep 2012
Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
HSMN NewsFeed - 19 Jun 2012
Covidien Launches World’s First Knotless Suture Reload for Laparoscopic and Single-Incision Procedures
Covidien Launches World’s First Knotless Suture Reload for Laparoscopic and Single-Incision Procedures
HSMN NewsFeed - 18 Jun 2012
Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program
Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program
HSMN NewsFeed - 4 Jun 2012
SentreHEART Secures $26 Million in Series C Financing for Commercialization
SentreHEART Secures $26 Million in Series C Financing for Commercialization
HSMN NewsFeed - 5 Apr 2012
Delcath Receives European Regulatory Approval for Second Generation Hemofiltration Cartridge
Delcath Receives European Regulatory Approval for Second Generation Hemofiltration Cartridge
HSMN NewsFeed - 22 Mar 2012
OrbusNeich's Genous(TM) Technology Effectively Promotes Endothelialization and Reduces Thrombogenicity
OrbusNeich's Genous(TM) Technology Effectively Promotes Endothelialization and Reduces Thrombogenicity
HSMN NewsFeed - 22 Feb 2012
Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
HSMN NewsFeed - 5 Jan 2012
NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System
NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System
HSMN NewsFeed - 30 Nov 2011
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
HSMN NewsFeed - 7 Sep 2011
MiCardia Corporation Receives CE Mark for the enCorSQ Mitral Valve Repair SystemTM
MiCardia Corporation Receives CE Mark for the enCorSQ Mitral Valve Repair SystemTM
HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
HSMN NewsFeed - 25 May 2011
Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
HSMN NewsFeed - 9 May 2011
Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer
Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer
HSMN NewsFeed - 14 Jan 2011
GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease
GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease
HSMN NewsFeed - 5 Jan 2011
Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
HSMN NewsFeed - 15 Dec 2010
EpiCept Announces Initiation by NCI of Phase II Trial with Crolibulin(TM) in Anaplastic Thyroid Cancer
EpiCept Announces Initiation by NCI of Phase II Trial with Crolibulin(TM) in Anaplastic Thyroid Cancer
HSMN NewsFeed - 7 Sep 2010
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
HSMN NewsFeed - 12 Aug 2010
Mercator Licenses Pioneering Technology from MD Anderson Cancer Center and Closes $2M Seed Round
Mercator Licenses Pioneering Technology from MD Anderson Cancer Center and Closes $2M Seed Round
HSMN NewsFeed - 17 Jun 2010
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
HSMN NewsFeed - 16 Jun 2010
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
HSMN NewsFeed - 27 Apr 2010
FDA Provides Clearance of TYRX Antibacterial Patch for Soft Tissue Repair
FDA Provides Clearance of TYRX Antibacterial Patch for Soft Tissue Repair
HSMN NewsFeed - 13 Apr 2010
New Anti-Bacterial Device Helps Reduce Infections Associated with Pacemaker and Defibrillator Implantation*
New Anti-Bacterial Device Helps Reduce Infections Associated with Pacemaker and Defibrillator Implantation*
HSMN NewsFeed - 25 Feb 2010
Adamis Pharmaceuticals Signs Agreement to Acquire Prostate Cancer Drug Candidates
Adamis Pharmaceuticals Signs Agreement to Acquire Prostate Cancer Drug Candidates
HSMN NewsFeed - 24 Nov 2009
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
HSMN NewsFeed - 17 Jul 2009
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
HSMN NewsFeed - 2 Jun 2009
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
HSMN NewsFeed - 2 Jun 2009
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
HSMN NewsFeed - 19 Mar 2009
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
HSMN NewsFeed - 11 Feb 2009
Genocea Biosciences Names Jane Halpern Vice President of Regulatory Affairs
Genocea Biosciences Names Jane Halpern Vice President of Regulatory Affairs
HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
HSMN NewsFeed - 29 Jan 2009
Immunomedics Reports Properties and Structure-Function Relationships of Veltuzumab
Immunomedics Reports Properties and Structure-Function Relationships of Veltuzumab
HSMN NewsFeed - 8 Jan 2009
WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
HSMN NewsFeed - 8 Oct 2008
Apieron, Inc. Announces Appointment of Holly McGarraugh as President and Chief Executive Officer
Apieron, Inc. Announces Appointment of Holly McGarraugh as President and Chief Executive Officer
HSMN NewsFeed - 30 Sep 2008
Lucid Receives FDA Clearance to Market Its VivaScope(R) Reflective Confocal Microscope System in the U.S.
Lucid Receives FDA Clearance to Market Its VivaScope(R) Reflective Confocal Microscope System in the U.S.
HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
HSMN NewsFeed - 28 Jul 2008
Arpida Submits Marketing Authorisation Application for Intravenous Iclaprim in Europe
Arpida Submits Marketing Authorisation Application for Intravenous Iclaprim in Europe
HSMN NewsFeed - 23 Jul 2008
Vaccine Executive Staph Bakali Joins Genocea Biosciences' Board of Directors
Vaccine Executive Staph Bakali Joins Genocea Biosciences' Board of Directors
HSMN NewsFeed - 23 Jul 2008
Palomar Medical Expands Its Product Portfolio Through a Distribution Agreement with Astron Clinica
Palomar Medical Expands Its Product Portfolio Through a Distribution Agreement with Astron Clinica
HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
HSMN NewsFeed - 14 Jul 2008
Synta Pharmaceuticals Names Michael P. Bailey Senior Vice President and Chief Commercial Officer
Synta Pharmaceuticals Names Michael P. Bailey Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 9 Jul 2008
ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve
ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve
HSMN NewsFeed - 29 May 2008
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
HSMN NewsFeed - 27 May 2008
EpiCept Files Re-Examination Documentation for Marketing Authorization of Ceplene(TM) in Europe
EpiCept Files Re-Examination Documentation for Marketing Authorization of Ceplene(TM) in Europe
HSMN NewsFeed - 20 May 2008
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
HSMN NewsFeed - 20 May 2008
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR
HSMN NewsFeed - 12 May 2008
HepaLife's Bioartificial Liver Exceeds Expectations in New Tests Conducted over Prolonged Periods of Time
HepaLife's Bioartificial Liver Exceeds Expectations in New Tests Conducted over Prolonged Periods of Time
HSMN NewsFeed - 9 Apr 2008
Meridian Bioscience Launches Two New TRU(TM) Brand Rapid Tests for the Detection of Epstein-Barr Virus
Meridian Bioscience Launches Two New TRU(TM) Brand Rapid Tests for the Detection of Epstein-Barr Virus
HSMN NewsFeed - 31 Mar 2008
TyRx Pharma, Inc. Announces the Appointment of Gary Young, PharmD, MBA as Vice President, Marketing
TyRx Pharma, Inc. Announces the Appointment of Gary Young, PharmD, MBA as Vice President, Marketing
HSMN NewsFeed - 11 Feb 2008
Regulus Therapeutics Appoints Peter S. Linsley, Ph.D. as Chief Scientific Officer
Regulus Therapeutics Appoints Peter S. Linsley, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 25 Jan 2008
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
HSMN NewsFeed - 7 Jan 2008
MIV Therapeutics Appoints Mark Landy to Additional Post of Chief Executive Officer
MIV Therapeutics Appoints Mark Landy to Additional Post of Chief Executive Officer
HSMN NewsFeed - 6 Dec 2007
Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting
Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting
HSMN NewsFeed - 3 Dec 2007
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
HSMN NewsFeed - 14 Nov 2007
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
HSMN NewsFeed - 8 Nov 2007
Neurochem announces important initiatives to provide medical and health benefits to patients
Neurochem announces important initiatives to provide medical and health benefits to patients
HSMN NewsFeed - 5 Nov 2007
Collagen Matrix, Inc. Receives FDA 510(k) Clearance for SynOss(TM) Synthetic Mineral Bone Graft Material
Collagen Matrix, Inc. Receives FDA 510(k) Clearance for SynOss(TM) Synthetic Mineral Bone Graft Material
HSMN NewsFeed - 22 Oct 2007
MIV Therapeutics Announces Positive Results From First Human Study With Its VESTASYNC Stent
MIV Therapeutics Announces Positive Results From First Human Study With Its VESTASYNC Stent
HSMN NewsFeed - 18 Sep 2007
Nile Therapeutics, Inc. Completes $20 Million Financing and Reverse Merger with SMI Products, Inc.
Nile Therapeutics, Inc. Completes $20 Million Financing and Reverse Merger with SMI Products, Inc.
HSMN NewsFeed - 12 Sep 2007
Innocoll Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
Innocoll Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
HSMN NewsFeed - 11 Sep 2007
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
HSMN NewsFeed - 30 Aug 2007
Competitive Technologies Obtains License Rights to Innovative Surgical Device
Competitive Technologies Obtains License Rights to Innovative Surgical Device
HSMN NewsFeed - 29 Aug 2007
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
HSMN NewsFeed - 29 Aug 2007
Wyeth and Progenics Submit Marketing Application in Australia for Subcutaneous Methylnaltrexone
Wyeth and Progenics Submit Marketing Application in Australia for Subcutaneous Methylnaltrexone
HSMN NewsFeed - 28 Aug 2007
Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
HSMN NewsFeed - 21 Aug 2007
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
HSMN NewsFeed - 31 Jul 2007
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
HSMN NewsFeed - 11 Jul 2007
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
HSMN NewsFeed - 5 Jun 2007
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
HSMN NewsFeed - 2 Jun 2007
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
HSMN NewsFeed - 29 May 2007
Micrus Endovascular Receives FDA Clearance for the ENZO Steerable Microcatheter
Micrus Endovascular Receives FDA Clearance for the ENZO Steerable Microcatheter
HSMN NewsFeed - 23 May 2007
Mediscience Technology Corp/BioScopix Names Dr. Fredrick Naftolin Chief Medical Officer
Mediscience Technology Corp/BioScopix Names Dr. Fredrick Naftolin Chief Medical Officer
HSMN NewsFeed - 16 May 2007
Zimmer Holdings and Regeneration Technologies Enter Distribution Agreement for New Allograft Paste Implant
Zimmer Holdings and Regeneration Technologies Enter Distribution Agreement for New Allograft Paste Implant
HSMN NewsFeed - 9 May 2007
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
HSMN NewsFeed - 1 May 2007
Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
HSMN NewsFeed - 9 Apr 2007
Tepha, Inc. Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers
Tepha, Inc. Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers
HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
HSMN NewsFeed - 21 Feb 2007
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
HSMN NewsFeed - 20 Feb 2007
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
HSMN NewsFeed - 31 Jan 2007
Alfacell Appoints David Sidransky M.D. as Vice Chairman and Lead Independent Director
Alfacell Appoints David Sidransky M.D. as Vice Chairman and Lead Independent Director
HSMN NewsFeed - 30 Jan 2007
PsychoGenics Announces the Launch of Psylin Neurosciences, Inc. in Partnership with Amylin Pharmaceuticals
PsychoGenics Announces the Launch of Psylin Neurosciences, Inc. in Partnership with Amylin Pharmaceuticals
HSMN NewsFeed - 29 Jan 2007
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
HSMN NewsFeed - 23 Jan 2007
Safety Monitoring Board Recommends Continuation of EntreMed's MKC-1 Phase 2 Breast Cancer Study
Safety Monitoring Board Recommends Continuation of EntreMed's MKC-1 Phase 2 Breast Cancer Study
Additional items found! 279
Members Archive contains
279 additional stories matching:
VIVO
(Password required)
VIVO
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!